Lergotrile (INN , USAN ) is an ergoline derivative which acts as a dopamine receptor agonist. It was developed for the treatment of Parkinson's disease, but failed in clinical trials due to liver toxicity.[1][2]
Clinical data | |
---|---|
Other names | LY-79907; 2-Chloro-6-methylergoline-8β-acetonitrile |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEMBL |
|
Chemical and physical data | |
Formula | C17H18ClN3 |
Molar mass | 299.80 g·mol−1 |
3D model (JSmol) |
|
| |
|